Global Equine Rhinopneumonitis Vaccine Supply, Demand and Key Producers, 2024-2030
Page: 109
Published Date: 03 Mar 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Equine Rhinopneumonitis Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Equine Rhinopneumonitis Vaccine can prevent Equine Rhinopneumonitis，viruses that are prevalent in horses and can cause outbreaks of respiratory disease.
This report studies the global Equine Rhinopneumonitis Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Equine Rhinopneumonitis Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Equine Rhinopneumonitis Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Equine Rhinopneumonitis Vaccine total production and demand, 2019-2030, (K Units)
Global Equine Rhinopneumonitis Vaccine total production value, 2019-2030, (USD Million)
Global Equine Rhinopneumonitis Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Equine Rhinopneumonitis Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Equine Rhinopneumonitis Vaccine domestic production, consumption, key domestic manufacturers and share
Global Equine Rhinopneumonitis Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Equine Rhinopneumonitis Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Equine Rhinopneumonitis Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Equine Rhinopneumonitis Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Nisseiken Co., Ltd., Boehringer Ingelheim, Santa Cruz Animal Health and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Equine Rhinopneumonitis Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Equine Rhinopneumonitis Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Equine Rhinopneumonitis Vaccine Market, Segmentation by Type
Live
Inactivated
Global Equine Rhinopneumonitis Vaccine Market, Segmentation by Application
Veterinary Pharmacy
Online Sale
Others
Companies Profiled:
Zoetis
Nisseiken Co., Ltd.
Boehringer Ingelheim
Santa Cruz Animal Health
Merck
Key Questions Answered
1. How big is the global Equine Rhinopneumonitis Vaccine market?
2. What is the demand of the global Equine Rhinopneumonitis Vaccine market?
3. What is the year over year growth of the global Equine Rhinopneumonitis Vaccine market?
4. What is the production and production value of the global Equine Rhinopneumonitis Vaccine market?
5. Who are the key producers in the global Equine Rhinopneumonitis Vaccine market?
Table of Contents
1 Supply Summary
1.1 Equine Rhinopneumonitis Vaccine Introduction
1.2 World Equine Rhinopneumonitis Vaccine Supply & Forecast
1.2.1 World Equine Rhinopneumonitis Vaccine Production Value (2019 & 2023 & 2030)
1.2.2 World Equine Rhinopneumonitis Vaccine Production (2019-2030)
1.2.3 World Equine Rhinopneumonitis Vaccine Pricing Trends (2019-2030)
1.3 World Equine Rhinopneumonitis Vaccine Production by Region (Based on Production Site)
1.3.1 World Equine Rhinopneumonitis Vaccine Production Value by Region (2019-2030)
1.3.2 World Equine Rhinopneumonitis Vaccine Production by Region (2019-2030)
1.3.3 World Equine Rhinopneumonitis Vaccine Average Price by Region (2019-2030)
1.3.4 North America Equine Rhinopneumonitis Vaccine Production (2019-2030)
1.3.5 Europe Equine Rhinopneumonitis Vaccine Production (2019-2030)
1.3.6 China Equine Rhinopneumonitis Vaccine Production (2019-2030)
1.3.7 Japan Equine Rhinopneumonitis Vaccine Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Equine Rhinopneumonitis Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Equine Rhinopneumonitis Vaccine Major Market Trends
2.1 World Equine Rhinopneumonitis Vaccine Demand (2019-2030)
2.2 World Equine Rhinopneumonitis Vaccine Consumption by Region
2.2.1 World Equine Rhinopneumonitis Vaccine Consumption by Region (2019-2024)
2.2.2 World Equine Rhinopneumonitis Vaccine Consumption Forecast by Region (2025-2030)
2.3 United States Equine Rhinopneumonitis Vaccine Consumption (2019-2030)
2.4 China Equine Rhinopneumonitis Vaccine Consumption (2019-2030)
2.5 Europe Equine Rhinopneumonitis Vaccine Consumption (2019-2030)
2.6 Japan Equine Rhinopneumonitis Vaccine Consumption (2019-2030)
2.7 South Korea Equine Rhinopneumonitis Vaccine Consumption (2019-2030)
2.8 ASEAN Equine Rhinopneumonitis Vaccine Consumption (2019-2030)
2.9 India Equine Rhinopneumonitis Vaccine Consumption (2019-2030)
3.1 World Equine Rhinopneumonitis Vaccine Production Value by Manufacturer (2019-2024)
3.2 World Equine Rhinopneumonitis Vaccine Production by Manufacturer (2019-2024)
3.3 World Equine Rhinopneumonitis Vaccine Average Price by Manufacturer (2019-2024)
3.4 Equine Rhinopneumonitis Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Equine Rhinopneumonitis Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Equine Rhinopneumonitis Vaccine in 2023
3.5.3 Global Concentration Ratios (CR8) for Equine Rhinopneumonitis Vaccine in 2023
3.6 Equine Rhinopneumonitis Vaccine Market: Overall Company Footprint Analysis
3.6.1 Equine Rhinopneumonitis Vaccine Market: Region Footprint
3.6.2 Equine Rhinopneumonitis Vaccine Market: Company Product Type Footprint
3.6.3 Equine Rhinopneumonitis Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Equine Rhinopneumonitis Vaccine Production Value Comparison
4.1.1 United States VS China: Equine Rhinopneumonitis Vaccine Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Equine Rhinopneumonitis Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Equine Rhinopneumonitis Vaccine Production Comparison
4.2.1 United States VS China: Equine Rhinopneumonitis Vaccine Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Equine Rhinopneumonitis Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Equine Rhinopneumonitis Vaccine Consumption Comparison
4.3.1 United States VS China: Equine Rhinopneumonitis Vaccine Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Equine Rhinopneumonitis Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Equine Rhinopneumonitis Vaccine Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Equine Rhinopneumonitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Equine Rhinopneumonitis Vaccine Production Value (2019-2024)
4.4.3 United States Based Manufacturers Equine Rhinopneumonitis Vaccine Production (2019-2024)
4.5 China Based Equine Rhinopneumonitis Vaccine Manufacturers and Market Share
4.5.1 China Based Equine Rhinopneumonitis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Equine Rhinopneumonitis Vaccine Production Value (2019-2024)
4.5.3 China Based Manufacturers Equine Rhinopneumonitis Vaccine Production (2019-2024)
4.6 Rest of World Based Equine Rhinopneumonitis Vaccine Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Equine Rhinopneumonitis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Equine Rhinopneumonitis Vaccine Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Equine Rhinopneumonitis Vaccine Production (2019-2024)
5.1 World Equine Rhinopneumonitis Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Live
5.2.2 Inactivated
5.3 Market Segment by Type
5.3.1 World Equine Rhinopneumonitis Vaccine Production by Type (2019-2030)
5.3.2 World Equine Rhinopneumonitis Vaccine Production Value by Type (2019-2030)
5.3.3 World Equine Rhinopneumonitis Vaccine Average Price by Type (2019-2030)
6.1 World Equine Rhinopneumonitis Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Veterinary Pharmacy
6.2.2 Online Sale
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Equine Rhinopneumonitis Vaccine Production by Application (2019-2030)
6.3.2 World Equine Rhinopneumonitis Vaccine Production Value by Application (2019-2030)
6.3.3 World Equine Rhinopneumonitis Vaccine Average Price by Application (2019-2030)
7.1 Zoetis
7.1.1 Zoetis Details
7.1.2 Zoetis Major Business
7.1.3 Zoetis Equine Rhinopneumonitis Vaccine Product and Services
7.1.4 Zoetis Equine Rhinopneumonitis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Zoetis Recent Developments/Updates
7.1.6 Zoetis Competitive Strengths & Weaknesses
7.2 Nisseiken Co., Ltd.
7.2.1 Nisseiken Co., Ltd. Details
7.2.2 Nisseiken Co., Ltd. Major Business
7.2.3 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product and Services
7.2.4 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Nisseiken Co., Ltd. Recent Developments/Updates
7.2.6 Nisseiken Co., Ltd. Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Details
7.3.2 Boehringer Ingelheim Major Business
7.3.3 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product and Services
7.3.4 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Boehringer Ingelheim Recent Developments/Updates
7.3.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.4 Santa Cruz Animal Health
7.4.1 Santa Cruz Animal Health Details
7.4.2 Santa Cruz Animal Health Major Business
7.4.3 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product and Services
7.4.4 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Santa Cruz Animal Health Recent Developments/Updates
7.4.6 Santa Cruz Animal Health Competitive Strengths & Weaknesses
7.5 Merck
7.5.1 Merck Details
7.5.2 Merck Major Business
7.5.3 Merck Equine Rhinopneumonitis Vaccine Product and Services
7.5.4 Merck Equine Rhinopneumonitis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Merck Recent Developments/Updates
7.5.6 Merck Competitive Strengths & Weaknesses
8.1 Equine Rhinopneumonitis Vaccine Industry Chain
8.2 Equine Rhinopneumonitis Vaccine Upstream Analysis
8.2.1 Equine Rhinopneumonitis Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Equine Rhinopneumonitis Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Equine Rhinopneumonitis Vaccine Production Mode
8.6 Equine Rhinopneumonitis Vaccine Procurement Model
8.7 Equine Rhinopneumonitis Vaccine Industry Sales Model and Sales Channels
8.7.1 Equine Rhinopneumonitis Vaccine Sales Model
8.7.2 Equine Rhinopneumonitis Vaccine Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Equine Rhinopneumonitis Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Equine Rhinopneumonitis Vaccine Production Value by Region (2019-2024) & (USD Million)
Table 3. World Equine Rhinopneumonitis Vaccine Production Value by Region (2025-2030) & (USD Million)
Table 4. World Equine Rhinopneumonitis Vaccine Production Value Market Share by Region (2019-2024)
Table 5. World Equine Rhinopneumonitis Vaccine Production Value Market Share by Region (2025-2030)
Table 6. World Equine Rhinopneumonitis Vaccine Production by Region (2019-2024) & (K Units)
Table 7. World Equine Rhinopneumonitis Vaccine Production by Region (2025-2030) & (K Units)
Table 8. World Equine Rhinopneumonitis Vaccine Production Market Share by Region (2019-2024)
Table 9. World Equine Rhinopneumonitis Vaccine Production Market Share by Region (2025-2030)
Table 10. World Equine Rhinopneumonitis Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Equine Rhinopneumonitis Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Equine Rhinopneumonitis Vaccine Major Market Trends
Table 13. World Equine Rhinopneumonitis Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Equine Rhinopneumonitis Vaccine Consumption by Region (2019-2024) & (K Units)
Table 15. World Equine Rhinopneumonitis Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Equine Rhinopneumonitis Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Equine Rhinopneumonitis Vaccine Producers in 2023
Table 18. World Equine Rhinopneumonitis Vaccine Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Equine Rhinopneumonitis Vaccine Producers in 2023
Table 20. World Equine Rhinopneumonitis Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Equine Rhinopneumonitis Vaccine Company Evaluation Quadrant
Table 22. World Equine Rhinopneumonitis Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Equine Rhinopneumonitis Vaccine Production Site of Key Manufacturer
Table 24. Equine Rhinopneumonitis Vaccine Market: Company Product Type Footprint
Table 25. Equine Rhinopneumonitis Vaccine Market: Company Product Application Footprint
Table 26. Equine Rhinopneumonitis Vaccine Competitive Factors
Table 27. Equine Rhinopneumonitis Vaccine New Entrant and Capacity Expansion Plans
Table 28. Equine Rhinopneumonitis Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Equine Rhinopneumonitis Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Equine Rhinopneumonitis Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Equine Rhinopneumonitis Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Equine Rhinopneumonitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Equine Rhinopneumonitis Vaccine Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Equine Rhinopneumonitis Vaccine Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Equine Rhinopneumonitis Vaccine Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Equine Rhinopneumonitis Vaccine Production Market Share (2019-2024)
Table 37. China Based Equine Rhinopneumonitis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Equine Rhinopneumonitis Vaccine Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Equine Rhinopneumonitis Vaccine Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Equine Rhinopneumonitis Vaccine Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Equine Rhinopneumonitis Vaccine Production Market Share (2019-2024)
Table 42. Rest of World Based Equine Rhinopneumonitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Equine Rhinopneumonitis Vaccine Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Equine Rhinopneumonitis Vaccine Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Equine Rhinopneumonitis Vaccine Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Equine Rhinopneumonitis Vaccine Production Market Share (2019-2024)
Table 47. World Equine Rhinopneumonitis Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Equine Rhinopneumonitis Vaccine Production by Type (2019-2024) & (K Units)
Table 49. World Equine Rhinopneumonitis Vaccine Production by Type (2025-2030) & (K Units)
Table 50. World Equine Rhinopneumonitis Vaccine Production Value by Type (2019-2024) & (USD Million)
Table 51. World Equine Rhinopneumonitis Vaccine Production Value by Type (2025-2030) & (USD Million)
Table 52. World Equine Rhinopneumonitis Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Equine Rhinopneumonitis Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Equine Rhinopneumonitis Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Equine Rhinopneumonitis Vaccine Production by Application (2019-2024) & (K Units)
Table 56. World Equine Rhinopneumonitis Vaccine Production by Application (2025-2030) & (K Units)
Table 57. World Equine Rhinopneumonitis Vaccine Production Value by Application (2019-2024) & (USD Million)
Table 58. World Equine Rhinopneumonitis Vaccine Production Value by Application (2025-2030) & (USD Million)
Table 59. World Equine Rhinopneumonitis Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Equine Rhinopneumonitis Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Zoetis Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Major Business
Table 63. Zoetis Equine Rhinopneumonitis Vaccine Product and Services
Table 64. Zoetis Equine Rhinopneumonitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Zoetis Recent Developments/Updates
Table 66. Zoetis Competitive Strengths & Weaknesses
Table 67. Nisseiken Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 68. Nisseiken Co., Ltd. Major Business
Table 69. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product and Services
Table 70. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Nisseiken Co., Ltd. Recent Developments/Updates
Table 72. Nisseiken Co., Ltd. Competitive Strengths & Weaknesses
Table 73. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 74. Boehringer Ingelheim Major Business
Table 75. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product and Services
Table 76. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Boehringer Ingelheim Recent Developments/Updates
Table 78. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 79. Santa Cruz Animal Health Basic Information, Manufacturing Base and Competitors
Table 80. Santa Cruz Animal Health Major Business
Table 81. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product and Services
Table 82. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Santa Cruz Animal Health Recent Developments/Updates
Table 84. Merck Basic Information, Manufacturing Base and Competitors
Table 85. Merck Major Business
Table 86. Merck Equine Rhinopneumonitis Vaccine Product and Services
Table 87. Merck Equine Rhinopneumonitis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 88. Global Key Players of Equine Rhinopneumonitis Vaccine Upstream (Raw Materials)
Table 89. Equine Rhinopneumonitis Vaccine Typical Customers
Table 90. Equine Rhinopneumonitis Vaccine Typical Distributors
List of Figure
Figure 1. Equine Rhinopneumonitis Vaccine Picture
Figure 2. World Equine Rhinopneumonitis Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Equine Rhinopneumonitis Vaccine Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Equine Rhinopneumonitis Vaccine Production (2019-2030) & (K Units)
Figure 5. World Equine Rhinopneumonitis Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 6. World Equine Rhinopneumonitis Vaccine Production Value Market Share by Region (2019-2030)
Figure 7. World Equine Rhinopneumonitis Vaccine Production Market Share by Region (2019-2030)
Figure 8. North America Equine Rhinopneumonitis Vaccine Production (2019-2030) & (K Units)
Figure 9. Europe Equine Rhinopneumonitis Vaccine Production (2019-2030) & (K Units)
Figure 10. China Equine Rhinopneumonitis Vaccine Production (2019-2030) & (K Units)
Figure 11. Japan Equine Rhinopneumonitis Vaccine Production (2019-2030) & (K Units)
Figure 12. Equine Rhinopneumonitis Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Equine Rhinopneumonitis Vaccine Consumption (2019-2030) & (K Units)
Figure 15. World Equine Rhinopneumonitis Vaccine Consumption Market Share by Region (2019-2030)
Figure 16. United States Equine Rhinopneumonitis Vaccine Consumption (2019-2030) & (K Units)
Figure 17. China Equine Rhinopneumonitis Vaccine Consumption (2019-2030) & (K Units)
Figure 18. Europe Equine Rhinopneumonitis Vaccine Consumption (2019-2030) & (K Units)
Figure 19. Japan Equine Rhinopneumonitis Vaccine Consumption (2019-2030) & (K Units)
Figure 20. South Korea Equine Rhinopneumonitis Vaccine Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Equine Rhinopneumonitis Vaccine Consumption (2019-2030) & (K Units)
Figure 22. India Equine Rhinopneumonitis Vaccine Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Equine Rhinopneumonitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Equine Rhinopneumonitis Vaccine Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Equine Rhinopneumonitis Vaccine Markets in 2023
Figure 26. United States VS China: Equine Rhinopneumonitis Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Equine Rhinopneumonitis Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Equine Rhinopneumonitis Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Equine Rhinopneumonitis Vaccine Production Market Share 2023
Figure 30. China Based Manufacturers Equine Rhinopneumonitis Vaccine Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Equine Rhinopneumonitis Vaccine Production Market Share 2023
Figure 32. World Equine Rhinopneumonitis Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Equine Rhinopneumonitis Vaccine Production Value Market Share by Type in 2023
Figure 34. Live
Figure 35. Inactivated
Figure 36. World Equine Rhinopneumonitis Vaccine Production Market Share by Type (2019-2030)
Figure 37. World Equine Rhinopneumonitis Vaccine Production Value Market Share by Type (2019-2030)
Figure 38. World Equine Rhinopneumonitis Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Equine Rhinopneumonitis Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Equine Rhinopneumonitis Vaccine Production Value Market Share by Application in 2023
Figure 41. Veterinary Pharmacy
Figure 42. Online Sale
Figure 43. Others
Figure 44. World Equine Rhinopneumonitis Vaccine Production Market Share by Application (2019-2030)
Figure 45. World Equine Rhinopneumonitis Vaccine Production Value Market Share by Application (2019-2030)
Figure 46. World Equine Rhinopneumonitis Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Equine Rhinopneumonitis Vaccine Industry Chain
Figure 48. Equine Rhinopneumonitis Vaccine Procurement Model
Figure 49. Equine Rhinopneumonitis Vaccine Sales Model
Figure 50. Equine Rhinopneumonitis Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Zoetis Nisseiken Co., Ltd. Boehringer Ingelheim Santa Cruz Animal Health Merck
Related Reports
10 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
